Trial for new Clot-Busting catheter withdrawn before starting
NCT ID NCT06975969
Summary
This study aimed to test a specialized catheter designed to deliver clot-dissolving medication directly to blood clots in the lungs. It planned to enroll up to 10 adults with serious but not massive lung clots. The trial was withdrawn by the sponsor before any patients were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Virginia Medical Center
Charlottesville, Virginia, 22903, United States
Conditions
Explore the condition pages connected to this study.